Proven Aspergillus flavus pulmonary aspergillosis in a COVID-19 patient: A case report and review of the literature.
Mohammad Reza SalehiNasim KhajaviradArash SeifiFaeze SalahshourBehnaz JahanbinHossein KazemizadehSayed Jamal HashemiSeyed Ali Dehghan ManshadiMohammad KordPaul E VerweijSadegh KhodavaisyPublished in: Mycoses (2021)
Severe COVID-19 patients complicated with aspergillosis are increasingly reported. We present a histopathological proven case of fatal COVID-19-associated pulmonary aspergillosis (CAPA), due to Aspergillus flavus. This report and existing published literature indicate diagnostic challenges and poor outcomes of CAPA in ICU patients.
Keyphrases
- sars cov
- coronavirus disease
- end stage renal disease
- pulmonary hypertension
- chronic kidney disease
- systematic review
- ejection fraction
- newly diagnosed
- intensive care unit
- peritoneal dialysis
- prognostic factors
- early onset
- metabolic syndrome
- case report
- cell wall
- mechanical ventilation
- adipose tissue
- patient reported outcomes